In the current work, we elaborated on the molecular and signaling mechanism of TGFBI mediating TAMs pro-tumor effect on GSCs and tried to explore the potential application of TGFBI as the index of TAM functionality and tumor burden in the clinical background. Here, TGFBI is linked to neoplasm.